# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-25-104319
Filing Date
2025-04-30
Accepted
2025-04-29 18:04:17
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-04-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | d920868dars.pdf | ARS | 9685126
| Complete submission text file | 0001193125-25-104319.txt |  | 13333193

Mailing Address 501 CANAL BLVD. RICHMOND CA 94084
Business Address 501 CANAL BLVD. RICHMOND CA 94084 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 000-30171 | Film No.: 25889861
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)